USA - NASDAQ:ALZN - US02262M6057 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ALZN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-25 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-08-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-17 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-16 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-04-12 | Maxim Group | Initiate | Buy |
| 2021-10-01 | Ascendiant Capital | Initiate | Buy |
8 analysts have analysed ALZN and the average price target is 42.84 USD. This implies a price increase of 1715.25% is expected in the next year compared to the current price of 2.36.
The consensus rating for ALZAMEND NEURO INC (ALZN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ALZAMEND NEURO INC (ALZN) is 8.